Indonesia launches rapid test kits domestically, called RI-GHA

Last updated on May 6th, 2021 at 10:24 am

Covid-19 positive patients in Indonesia continue to grow. Based on data from the Covid-19 Handling Task Force, there were 2,657 new positive cases, so that until Thursday (9/7), a total of 70,736 cases was recorded.

In an effort to handle Covid-19 across the country, the government launched a domestic rapid test tool called the RI-GHA Covid-19.

Minister of Research and Technology/Head of the National Research and Innovation Agency (Menristek/Head of BRIN) Bambang P.S Brodjonegoro said this tool was a collaboration with the Agency for Application and Assessment of Technology (BPPT), Gadjah Mada University, Airlangga University, Bandung Institute of Technology, Mataram University, and company PT Hepatika Mataram.

The government targets to produce 200 thousand rapid test tools in July and 400 thousand in August 2020.

Head of BPPT Hammam Riza said the rapid test equipment of domestic production is superior in quality and price compared to imported products. One unit of rapid test equipment made in the country costs Rp. 75,000.

“We believe that this rapid test product in the country is able to compete in the market and at lower prices. We must be prepared to compete in price with the same quality. It has to. If not, I am worried that we will continue to be crushed by imported products, “said Coordinating Minister for PMK Muhadjir Effendy in Jakarta, Thursday, July 9.

According to him, the supply of domestic products was in accordance with President Joko Widodo’s direction. Namely, the existence of regulations relating to government spending is simplified. In fact, government spending must also prioritize domestic products. Because this is considered to be able to spur economic growth in Indonesia.

Muhadjir greatly appreciated the findings of the country’s children in the form of the rapid test tool. The tool is staying able to be a solution for meeting the needs of medical devices that have been very urgent in Indonesia.

The same thing was said by Bambang that said the rapid test is one of the important elements in handling COVID-19. This rapid test tool has been tested for sensitivity (98 percent) and specificity (96 percent) through laboratory tests on Indonesians. This test tool is quite flexible because it is able to detect people without symptoms, people in monitoring, patient under surveillance, and post-infection

Noto

Jakarta-based Newswriter for The Asian Affairs. A budding newswriter that always keep track of the latest trends and news that are happening in my country Indonesia.

Recent Posts

China and UAE Celebrate 40 Years of Diplomatic Relations: All the Sectors for Partnership

Celebrating 40 years of diplomatic ties, China and the United Arab Emirates (UAE) are poised to fortify an alliance that…

November 2, 2024

What’s in Store for Squid Game Season 2: New Twists, International Adaptations, and a Bold Return to the Games

Fans of the worldwide sensation Squid Game have much to look forward to this December as the show's producer, Hwang…

November 2, 2024

TWICE Joins Coldplay’s ‘Music of the Spheres’ Tour for a Seoul Spectacle in 2025

Especially when it's the internationally known British rock band Coldplay linking up with K-pop phenomenon TWICE, few events match the…

November 2, 2024

China Caught in the Crossfire: Tensions Rise as North Korea and Russia Strengthen Alliance

Tucked on a 12-story structure in northeast China, visitors flock to get a rare view of the junction of their…

November 2, 2024

Could Westeros Dragons Soon Soar into the Big Screen? ‘Game of Thrones’ Film Reportedly in Early Development

HBO's Game of Thrones has created a void in the fantasy world of television that no other show has quite…

November 1, 2024

Preparing for U.S. Election Impact: Sen. Imee Marcos Urges Self-Reliant Defense Amid Uncertain Times

Head of the Senate Committee on Foreign Relations, Senator Imee Marcos underlined the need of the Philippines getting ready for…

November 1, 2024

This website uses cookies.

Read More